Polymorphic and amorphous forms of Rebaudioside X and methods for preparing the same are provided herein. Compounds of the present invention can be used for the treatment of diseases where Serum Amyloid P Component depletion has a beneficial effect, in particular in the treatment or prevention of central and systemic amyloidosis. The display portion is illuminated in accordance with a luminance of a subject.